pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Receptor tyrosine-protein kinase erbB-3DNA topoisomerase 1
Daiichi Sankyo Co Ltd
0 catalysts
Phase 3
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
PI3-kinase class I
$KZIAKAZIA THERAPEUTICS LTD
0 catalysts
Marketed
pazopanib hydrochloride
← prev
page 54 of 62
next →
131
Pain89
Neurology1
Pazopanib Hydrochloride (pazopanib hydrochloride)
Renal Cell Carcinoma
Novugen Pharma (Malaysia) Sdn Bhd
0 catalysts
pre_registration
pegargiminase
Malignant Pleural Mesothelioma
$PIIPolaris Inc.
0 catalysts
Marketed
pegaspargase
Oncaspar (pegaspargase)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Servier Pharmaceuticals LLC
0 catalysts
Preclinical
pegfilgrastim biosimilar
Fylnetra (pegfilgrastim-pbbk)
Unspecified Cancer
Meitheal Pharmaceuticals Inc
0 catalysts
Phase 3
pelabresib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bromodomain and extra-terminal motif (BET)
$NVSNOVARTIS AG
0 catalysts
Phase 2
pelareorep
Reolysin (pelareorep)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ONCYONCOLYTICS BIOTECH INC
0 catalysts
Phase 2
pelcitoclax
pelcitoclax [INN]
Neuroendocrine Tumors
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 2
peltopepimut-s
Cervical Cancer
ISA Pharmaceuticals BV
0 catalysts
Phase 2
peluntamig
Neuroendocrine Carcinoma
Phanes Therapeutics Inc
0 catalysts
Phase 1
pembrolizumab biosimilar
Melanoma
Formycon AG
0 catalysts
Marketed
pemetrexed
Pemfexy (pemetrexed [INN])
Malignant Pleural Mesothelioma
Eagle Pharmaceuticals Inc
0 catalysts
Marketed
pemetrexed tromethamine
Pemetrexed Ditromethamine (pemetrexed tromethamine)
Malignant Pleural Mesothelioma
Hospira Inc
0 catalysts
Marketed
pemigatinib
Pemazyre (pemigatinib)
Metastatic Bile Duct Cancer
Fibroblast growth factor receptor 3Fibroblast growth factor receptor 1
$INCYINCYTE CORP
0 catalysts
Marketed
penpulimab
Penpulimab-Kcqx (penpulimab)
Nasopharyngeal Cancer
Akeso Inc
0 catalysts
Marketed
pertuzumab
Perjeta (pertuzumab)
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Genentech Inc
0 catalysts
Phase 3
petosemtamab
Recurrent Head And Neck Squamous Cell Carcinoma
Merus NV
0 catalysts
Phase 2
pexastimogene devacirepvec
Metastatic Renal Cell Carcinoma
Granulocyte-macrophage colony-stimulating factor
Sillajen Biotherapeutics
0 catalysts
Marketed
pexidartinib hydrochloride
Turalio (pexidartinib hydrochloride)
Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co Ltd
0 catalysts
Marketed
phenoxybenzamine hydrochloride
Phenoxybenzamine Hydrochloride (phenoxybenzamine hydrochloride)
Pheochromocytoma
Novitium Pharma LLC
0 catalysts
Phase 1
pidnarulex
pidnarulex [INN]
Prostate Cancer
Senhwa Biosciences Inc
0 catalysts
Phase 2
pifusertib
pifusertib [INN]
Solid Tumor
Taiho Pharmaceutical Co Ltd
0 catalysts
pre_registration
pimicotinib hydrochloride
Tenosynovial Giant Cell Tumor
Abbisko Therapeutics Co Ltd
0 catalysts
Phase 1
pinometostat
pinometostat [INN]
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Ipsen SA
0 catalysts
Preclinical
piperlongumine
Recurrent Glioblastoma Multiforme (GBM)
TargTex SA
0 catalysts
Marketed
pirtobrutinib
Jaypirca (pirtobrutinib)
Chronic Lymphocytic Leukemia (CLL)
Tyrosine-protein kinase BTK
Eli Lilly and Co
0 catalysts
pre_registration
pivekimab sunirine
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Interleukin-3 receptor subunit alpha
$ABBVAbbVie Inc.
0 catalysts
Phase 3
plinabulin
Febrile Neutropenia
Tubulin
$BYSIBeyondSpring Inc.
0 catalysts
Phase 2
plixorafenib
Central Nervous System (CNS) Tumor
Serine/threonine-protein kinase B-raf
Fore Biotherapeutics Inc
0 catalysts